 Prolyl-Hydroxylase Inhibitors
"Prolyl-Hydroxylase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit the action of HYDROXYLASES that act on PROLINE to form HYDROXYPROLINE.
| Descriptor ID |
D064800
|
| MeSH Number(s) |
D27.505.519.389.740
|
| Concept/Terms |
Prolyl-Hydroxylase Inhibitors- Prolyl-Hydroxylase Inhibitors
- Inhibitors, Prolyl-Hydroxylase
- Prolyl Hydroxylase Inhibitors
- Proline Dioxygenase Inhibitors
- Dioxygenase Inhibitors, Proline
- Inhibitors, Proline Dioxygenase
- Proline Hydroxylase Inhibitors
- Hydroxylase Inhibitors, Proline
- Inhibitors, Proline Hydroxylase
|
Below are MeSH descriptors whose meaning is more general than "Prolyl-Hydroxylase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Prolyl-Hydroxylase Inhibitors".
This graph shows the total number of publications written about "Prolyl-Hydroxylase Inhibitors" by people in this website by year, and whether "Prolyl-Hydroxylase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 | | 2015 | 0 | 1 | 1 | | 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Prolyl-Hydroxylase Inhibitors" by people in Profiles.
-
Wang RX, Henen MA, Lee JS, V?geli B, Colgan SP. Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor. Gut Microbes. 2021 Jan-Dec; 13(1):1938380.
-
Lakhter AJ, Lahm T, Broxmeyer HE, Naidu SR. Golgi Associated HIF1a Serves as a Reserve in Melanoma Cells. J Cell Biochem. 2016 Apr; 117(4):853-9.
-
Olson E, Demopoulos L, Haws TF, Hu E, Fang Z, Mahar KM, Qin P, Lepore J, Bauer TA, Hiatt WR. Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease. Vasc Med. 2014 Dec; 19(6):473-82.
-
Keely S, Campbell EL, Baird AW, Hansbro PM, Shalwitz RA, Kotsakis A, McNamee EN, Eltzschig HK, Kominsky DJ, Colgan SP. Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis. Mucosal Immunol. 2014 Jan; 7(1):114-23.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|